Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03198390 · ClinicalTrials.gov registry record
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
A clinical trial, sponsored by University of Arizona.
- Terminated
- Registry status
- 100
- Enrollment target
NCT03198390 is a clinical trial that was terminated before completion, run by University of Arizona. The registered enrollment target is 100 participants.
The verdict
NCT03198390 was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Investigators will sample the skin and blood of patients with chronic skin conditions (including but not limited to atopic dermatitis (AD), contact dermatitis, hidradenitis suppurativa (HS), and psoriasis) to study the expression of anti-oxidative enzymes, skin barrier proteins and inflammatory molecules. In patients with atopic dermatitis, investigators will also measure skin barrier function using noninvasive devices. These results will be correlated with the disease severity in atopic dermatitis patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2020-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03198390
The ClinicalTrials.gov registry entry for NCT03198390 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03198390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03198390 about?
NCT03198390 is a clinical study titled "Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions". Investigators will sample the skin and blood of patients with chronic skin conditions (including but not limited to atopic dermatitis (AD), contact dermatitis, hidradenitis suppurativa (HS), and psoriasis) to study the expression of anti-oxidative enzymes, skin barrier proteins and inflammatory mole...
What is the current status of trial NCT03198390?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2017-08-04. Estimated completion is 2020-05-31.
Who is sponsoring clinical trial NCT03198390?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.